RMTI
NASDAQ
$0.62
Rockwell Medical Inc (RMTI)
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.
Sector:
Healthcare
Strong Buy
Target: $3 (+380.15%)
Market Cap
$26M
P/B Ratio
0.76
Free Cash Flow Yield
10.10%
Beta (5Y)
1.25
Price Chart
Valuation
Market Cap$26M
Forward P/E59.17
P/S0.40
P/B0.76
Profitability
Total Revenue (TTM)$68M
Gross Profit (TTM)$12M
EBITDA-$2.65M
Profit Margin-9.3%
Operating Margin-8.5%
EPS-$0.14
Financial Health
Debt-to-Equity24.9%
Free Cash Flow Yield10.10%
Growth & Risk
EPS 5Y CAGR-48.34%
Revenue 5Y CAGR+1.83%
Beta (5Y)1.25
Sharpe Ratio-0.19